CVE-2025-2229
Philips Intellispace Cardiovascular (ISCV) Use of Weak Credentials
A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
8.5
Philips Intellispace Cardiovascular (ISCV) Use of Weak Credentials
A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.
- Record
CVE-2025-2229- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N - CVSS 3.1
- 7.7 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-1391
- Updated
- 2026-11-02
EUVDEUVD-2025-6389
8.5
A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.
- Record
EUVD-2025-6389- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-x7gm-m6fc-fx8q
8.5
A token is created using the username, current date/time, and a fixed AES-128 encryption key,...
A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.
- Record
GHSA-x7gm-m6fc-fx8q- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 7.7 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-1391
- Updated
- 2026-11-02
NVD
8.5
A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.
- Record
CVE-2025-2229- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 7.7 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-1391
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-2229 is a high vulnerability (CVSS 8.5) in Philips Intellispace Cardiovascular (iscv), published March 13, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.13%, the 2nd percentile. No source names a fixed version.